Related references
Note: Only part of the references are listed.Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of Enterobacterales Isolates: Results from a Multilaboratory Study
Helio S. Sader et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula
Agnes Sonnevend et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant Enterobacteriaceae Isolates Collected from Three Secondary Hospitals in Southwest China Between 2018 and 2019
Chunhong Zou et al.
INFECTION AND DRUG RESISTANCE (2020)
In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea
Taeeun Kim et al.
ANTIBIOTICS-BASEL (2020)
Steady-State Ceftazidime-Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration
Paige Soukup et al.
PHARMACOTHERAPY (2019)
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
Gary E. Stein et al.
SURGICAL INFECTIONS (2019)
Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
Anushree Ulhas Amladi et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
Ryan K. Shields et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Avibactam Pharmacokinetic/Pharmacodynamic Targets
Wright W. Nichols et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests
Warawut Laolerd et al.
MICROBIAL DRUG RESISTANCE (2018)
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
Elizabeth Temkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Laura J. Rojas et al.
CLINICAL INFECTIOUS DISEASES (2017)
The global epidemiology of carbapenemase-producing Enterobacteriaceae
David van Duin et al.
VIRULENCE (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy
Darren Wong et al.
DRUGS (2017)
Molecular Epidemiology and Genome Dynamics of New Delhi Metallo-β-Lactamase-Producing Extraintestinal Pathogenic Escherichia coli Strains from India
Amit Ranjan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2016)
Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
Marco Falcone et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Colistin, mechanisms and prevalence of resistance
Abed Zahedi Bialvaei et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J. Morrill et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand
Thidarat Netikul et al.
PLOS ONE (2015)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand
Benchamas Rimrang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Dongeun Yong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
